BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial

Fielding, R. A., Dao, M. M., Cannon, K., Desvarieux, M., Miller, S. S., Gimness, M. P., Brandon, D. M., Villareal, D. T., Bruyere, O., Bautmans, I., Rickner, K., Perry, R., Kritchevsky, S. B., Musi, N., Chehade, J. M., Kirstein, J. L., Gielen, E., Pickrell, P., Dilda, P., … Veillet, S. (2025). BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double‐Blind Randomised Interventional Phase 2b Trial. Journal of Cachexia, Sarcopenia and Muscle, 16(2). Portico. https://doi.org/10.1002/jcsm.13750
Authors:
Roger A Fielding
Michael M Dao
Kevin Cannon
Moise Desvarieux
Sam S Miller
Michael Paul Gimness
Donald M Brandon
Dennis T Villareal
Olivier Bruyere
Ivan Bautmans
Kyle Rickner
Robert Perry
Stephen B Kritchevsky
Nicolas Musi
Joe M Chehade
Judith L Kirstein
Evelien Gielen
Paul Pickrell
Pierre Dilda
Rene Lafont
Carole Margalef
Yves Rolland
Susanna Del Signore
Jean Mariani
Samuel Agus
Cendrine Tourette
Waly Dioh
Rob van Maanen
Stanislas Veillet
Affiliated Authors:
Moise Desvarieux
Subjects:
Sarcopenia (MeSH)
Author Keywords:
20‐hydroxyecdysone
bio101
clinical trial
gait speed
mobility disability
sarcopenia
Publication Type:
Article
Unique ID:
10.1002/jcsm.13750
PMID:
Publication Date:
Data Source:
PubMed

Record Created: